Stay updated on Isatuximab Combo in High-Risk Smoldering MM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.

Latest updates to the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer’s revision number changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check22 days agoChange DetectedThe Dec. 5, 2025 version of the study record now lists References among its changes. An NIH notice about the transition from “AI” to “SI” also appears at the top of the page.SummaryDifference0.5%

- Check29 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check57 days agoChange DetectedThe history list now shows a newer revision tag, v3.7.0, replacing the previous v3.6.6 tag, indicating an update to the page's revision history.SummaryDifference0.1%

- Check78 days agoChange DetectedThe study record history now includes a new revision entry v3.6.6, replacing the previous v3.6.5 entry in the revision list.SummaryDifference0.1%

Stay in the know with updates to Isatuximab Combo in High-Risk Smoldering MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.